Description
Reduci contains the active substance lercanidipine hydrochloride, which belongs to a group of medicines called “calcium channel blockers” (dihydropyridine derivatives), which work by opening and relaxing blood vessels, allowing the blood to pass through them more easily. This lowers blood pressure and allows the heart to work more efficiently.
Indications
Reduci is indicated in adults for the treatment of mild to moderate essential
hypertension. (not recommended for children under 18 years of age).
Medicinal product subject to medical prescription.
Strengths and pharmaceutical form: 10 mg; 20 mg film-coated tablets